Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender
- PMID: 37920304
- PMCID: PMC10618777
- DOI: 10.1016/j.ssmph.2023.101540
Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender
Abstract
Objective: To investigate the joint impact of sexual orientation, gender identity, and race/ethnicity on colorectal and breast cancer screening disparities in the United States.
Methods: Utilizing sampling weighted data from the 2016 and 2018 Behavioral Risk Factor Surveillance System, we assessed differences in two metrics via chi-square statistics: 1) lifetime uptake, and 2) up-to-date colorectal and breast cancer screening by sexual orientation and gender identity, within and across racial/ethnic classifications.
Results: Within specific races/ethnicities, lifetime CRC screening was higher among gay/lesbian (within NH-White, Hispanic, and Asian/Pacific Islander) and bisexual individuals (Hispanic) compared to straight individuals, and lowest overall among transgender women and transgender nonconforming populations (p < 0.05). Asian transgender women had the lowest lifetime CRC screening (13.0%; w.n. = 1,428). Lifetime breast cancer screening was lowest among the Hispanic bisexual population (86.6%; w.n. = 26,940) and Hispanic transgender nonconforming population (71.8%; w.n. = 739); within all races, SGM individuals (except NH-White, Hispanic, and Black bisexual populations, and NH-White transgender men) had greater breast cancer screening adherence compared to straight individuals.
Conclusions: Due to small, unweighted sample sizes, results should be interpreted with caution. Heterogeneity in screening participation by SGM status within and across racial/ethnic groups were observed, revealing the need to disaggregate data to account for intersecting identities and for studies with larger sample sizes to increase estimate reliability.
Keywords: Breast cancer screening; Colorectal cancer screening; Gender minority health; Intersectionality; Screening disparities; Sexual minority health.
© 2023 The Authors.
Conflict of interest statement
All authors of this article declare they have no relevant conflicts of interest.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10618777/bin/gr1.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10618777/bin/gr2.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10618777/bin/gr3.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10618777/bin/gr4.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10618777/bin/gr5.gif)
Similar articles
-
Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity.Cancer Causes Control. 2024 Jan;35(1):133-151. doi: 10.1007/s10552-023-01771-2. Epub 2023 Aug 21. Cancer Causes Control. 2024. PMID: 37599335 Free PMC article.
-
The State of the Research on Opioid Outcomes Among Lesbian, Gay, Bisexual, Transgender, Queer, and Other Sexuality- and Gender-Diverse Populations: A Scoping Review.LGBT Health. 2023 Jan;10(1):1-17. doi: 10.1089/lgbt.2022.0036. Epub 2022 Oct 31. LGBT Health. 2023. PMID: 36318023 Free PMC article. Review.
-
Complicating Narratives of Sexual Minority Mental Health: An Intersectional Analysis of Frequent Mental Distress at the Intersection of Sexual Orientation, Gender Identity, and Race/Ethnicity.LGBT Health. 2022 Apr;9(3):161-168. doi: 10.1089/lgbt.2021.0099. Epub 2022 Feb 17. LGBT Health. 2022. PMID: 35180360
-
Substance Use Disparities at the Intersection of Sexual Identity and Race/Ethnicity: Results from the 2015-2018 National Survey on Drug Use and Health.LGBT Health. 2020 Aug/Sep;7(6):283-291. doi: 10.1089/lgbt.2019.0352. Epub 2020 Jun 15. LGBT Health. 2020. PMID: 32543315 Free PMC article.
-
Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.J Am Coll Radiol. 2019 Apr;16(4 Pt B):607-620. doi: 10.1016/j.jacr.2019.02.042. J Am Coll Radiol. 2019. PMID: 30947895
Cited by
-
A contemporary review of breast cancer risk factors and the role of artificial intelligence.Front Oncol. 2024 Apr 18;14:1356014. doi: 10.3389/fonc.2024.1356014. eCollection 2024. Front Oncol. 2024. PMID: 38699635 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources